. 2024 Aug 20;25(8):294. doi: 10.31083/j.rcm2508294

Table 6.

Trend analysis of different levels of PIV and the occurrence of MACE.

		Model 1		Model 2		Model 3
		OR (95% CI)	p value	OR (95% CI)	p value	OR (95% CI)	p value
LnPIV		2.31 (1.83, 2.91)	$<$ 0.0001	2.31 (1.83, 2.93)	$<$ 0.0001	2.27 (1.73, 2.98)	$<$ 0.0001
LnPIV Quartile
	LnPIV $\leq$ 5.52	1.0		1.0		1.0
	5.52 $<$ LnPIV $\leq$ 6.18	1.45 (0.79, 2.68)	0.2299	1.47 (0.79, 2.73)	0.2211	1.81 (0.93, 3.51)	0.0808
	6.18 $<$ LnPIV $\leq$ 6.76	2.01 (1.11, 3.63)	0.0204	2.03 (1.12, 3.68)	0.0204	2.35 (1.22, 4.51)	0.0104
	LnPIV $\geq$ 6.76	6.51 (3.68, 11.49)	$<$ 0.0001	6.78 (3.80, 12.10)	$<$ 0.0001	6.89 (3.56, 13.32)	$<$ 0.0001
LnPIV for trend		1.88 (1.57, 2.25)	$<$ 0.0001	1.90 (1.58, 2.28)	$<$ 0.0001	1.86 (1.51, 2.29)	$<$ 0.0001

Model 1: No adjustment model.

Model 2: Adjusted for age, male, smoking, diabetes, hypertension.

Model 3: Adjusted for age, male, smoking, diabetes, hypertension, systolic perssure, diastolic perssure, heart rate, BUN, creatinine, eGFR, UA, TP, TG, TC, Gensiniscore, LVEF, LVFS, and Killip class2–4.

LnPIV, natural logarithmic transformation of pan-immune-inflammation values; MACE, major adverse cardiovascular events; BUN, blood urea nitrogen; UA, uric acid; TC, cholesterol; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; eGFR, glomerular filtration rate; PIV, Pan-immune-inflammation value; TP, total protein; TG, triglyceride.